Related Experiment Video
Updated: Jul 31, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
An overview of myelodysplastic syndromes
Gina Pontrelli1, Carina Loscalzo, Mark L'Eplattenier
1Gina Pontrelli, Carina Loscalzo , and Mark L'Eplattenier are assistant professors in the PA program at Hofstra University in Hempstead, N.Y. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Myelodysplastic syndromes (MDS) can present as a cytopenia-often as unexplained anemia. Because MDS can progress to acute myelogenous leukemia, primary care providers should be aware of the signs and symptoms, which are associated with the corresponding cytopenia that patients experience and may include fatigue, infection, easy bruising, and bleeding. Treatment options center on managing related cytopenias. The only cure, stem cell transplant, is not readily available.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Cardiomyopathy I: Introduction and Classification
Mitral Stenosis I: Introduction
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Abnormal Proliferation
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

